The Trp64Arg β3-adrenergic receptor amino acid variant confers increased sensitivity to the pressor effects of noradrenaline in Sardinian subjects

Clinical Science

Volumn 103, Issue 4, 2002, Pages 397-402

  Melis, Maria G ^a   Secchi, Giannina ^a   Brizzi, Patrizia ^a   Severino, Cristiana ^a   Maioli, Mario ^a   Tonolo, Giancarlo ^a  

^a Istituto di Clinica Medica   (Italy)

Author keywords

Metabolic syndrome; Noradrenaline; Triacylglycerol; Type II diabetes

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; FATTY ACID; GELATIN; GLUCOSE; NORADRENALIN; TRIACYLGLYCEROL; TRYPTOPHAN; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; ITALY; MALE; NORADRENALIN BLOOD LEVEL; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BLOOD PRESSURE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; DOUBLE-BLIND METHOD; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-3; TRIGLYCERIDES; VASOCONSTRICTOR AGENTS;

EID: 0036796752     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs1030397     Document Type: Article

References (35)

1. Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F. P. and Brown, G. (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature (London) 214, 597-598
2. Bylund, D. V., Einkenberg, D. C., Hieble, J. P. et al. (1994) International union of pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46, 121-136
3. Hoffstedt, J., Shimizu, M., Sjosted, S. and Lonnqvist, F. (1995) Determination of beta-3 adrenergic receptor mediated lipolysis in human fat cells. Obes. Res. 3, 447-457
4. 3-adrenergic receptor. Annu. Rev. Pharmacol. Toxicol. 37, 421-450
5. 3-adrenergic receptor in man. Br. J. Pharmacol. 110, 929-936
6. Shen, Y. T., Zhang, H. and Vatner, F. (1994) Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs. J. Pharmacol. Exp. Ther. 268, 466-473
7. 3-adrenergic receptor in human heart. J. Clin. Invest. 98, 556-562
8. 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333, 348-351
9. Walston, J., Silver, K., Bogardus, C. et al. (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N. Engl. J. Med. 333, 343-347
10. 3-adrenergic receptor variant and lipid metabolism in Pima Indians. Diabetologia 40, 123-124
11. Tonolo, G., Melis, M. G., Secchi, G. et al. (1999) Association of Trp64Arg Beta3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. J. Hypertens. 17, 33-38
12. Shima, Y., Tsukada, T., Nakanishi, K. and Ohta, H. (1998) Association of the Trp64Arg mutation of the Beta3-adrenergic-receptor with fatty liver and mild glucose intolerance in Japanese subjects. Clin. Chim. Acta 274, 167-176
13. Buetter, R., Schaffler, A. and Arndt, H. (1998) The Trp64Arg polymorphism of the Beta3-adrenergic-receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J. Clin. Endocrinol. Metab. 83, 2892-2897
14. 3-adrenoreceptor gene polymorphism and beta blockers on triacylglycerol and HDL concentrations. Diabetologia 44, 115-122
15. Tonolo, G., Ciccarese, M., Melis, M. G. et al. (1998) A resource for studying gene-environment interrelations in type 2 diabetes. Diabetes Nutr. Metab. 11, 157-168
16. Berkin, K. E., Inglis, G. C., Ball, S. G. and Thomson, N. C. (1986) Effect of low dose adrenaline and noradrenaline infusions on airway calibre in asthmatic patients. Clin. Sci. 70, 347-352
17. Tonolo, G., Ciccarese, M., Brizzi, P. et al. (1995) Cyclical variation of plasma lipids, apolipoproteins and lipoprotein(a) during menstrual cycle in normal women. Am. J. Physiol. 269, E1101-E1105
18. Friedewald, W. T., Levy, R. I. and Fredrickson, S. (1972) Estimate of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-504
19. Blaak, E. E., Saris, W. H. M. and Van Baak, M. A. (1993) Adrenoceptor subtypes mediating catecholamine-induced thermogenesis in man. Int. J. Obes. 17, S78-S81
20. Ciccarese, M., Tonolo, G., Delin, I. et al. (1997) Preliminary data on a wide genome search in NIDDM siblings; the NIDDM1 locus on chromosome 2 is not linked to NIDDM in the Sardinian population. Diabetologia 14, 1366-1367
21. Tonolo, G., Melis, M. G., Ciccarese, M. et al. (1997) Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population. Diabetologia 40, 89-94
22. Shimizu, M., Blaak, E. E., Lonnqvist, F., Gafvels, M. E. and Arner, P. (1996) Agonist and antagonist properties of beta3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes. Pharmacol. Toxicol. 78, 254-263
23. Li, L. S., Lonnqvist, F., Luthman, H. and Arner, P. (1996) Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39, 857-860
24. Enocksson, S., Shimizu, M., Lonnqvist, F., Nordenstrom, J. and Arner, P. (1995) Demonstration of an in vivo functional beta 3 adrenoceptor in man. J. Clin. Invest. 95, 2239-2245
25. Bousquet-Mèlou, A., Galitzky, J., Carpènè, C., Lafontan, M. and Berlan, M. (1994) β-adrenergic control of lipolysis in primate white fat cells: a comparative study in non primate mammals. Am. J. Physiol. 267, R115-R123
26. Langin, D., Tavernier, G. and Lafontan, M. (1995) Regulation of beta 3-adrenoceptor expression in white fat cells. Fund. Clin. Pharmacol. 9, 97-106
27. Chaudhry, A. and Granneman, J. G. (1999) Differential regulation of functional responses by β-adrenergic receptor subtypes in brown adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 277, R147-R153
28. Balletshofer, B. M., Ritting, K., Volk, A. et al. (2001) Impaired non-esterified fatty acid suppression is associated with endothelial dysfunction in insulin resistant subjects. Horm. Metab. Res. 33, 428-431
29. Egan, B. M., Greene, E. L. and Goodfriend, T. L. (2001) Nonesterified fatty acids in blood pressure control and cardiovascular complications. Curr. Hypertens. Rep. 3, 107-116
30. Steinberg, H. O., Tarshoby, M., Monstrel, R. et al. (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilatation. J. Clin. Invest. 100, 1230-1239
31. Lind, L., Fugmann, A., Branth, S. et al. (2000) The impairment in endothelial function induced by non-esterified fatty acids can be reversed by insulin. Clin. Sci. 99, 169-174
32. Carlsson, M., Orho-Melander, M., Hedenbro, J. and Groop, L. C. (2001) Common variants in the beta 2 (Gln27Glu) and beta 3 (Trp64Arg) adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes. Diabetologia 44, 629-636
33. Risch, N. and Merikangas, K. (1996) The future of genetic studies of complex human disease. Science 273, 1516-1517
34. Cappello, N., Rendine, S., Griffo, R. et al. (1996) Genetic analysis of Sardinia: I. Data on 12 polymorphisms in 21 linguistic domains. Ann. Hum. Genet. 60, 125-141
35. Piazza, A. (1993) Who are the Europeans? Science 260, 1767-1769